Summit receives investment from U. of Colorado Anschutz Medical Campus CDI Fund

Summit receives investment from U. of Colorado Anschutz Medical Campus CDI Fund

AURORA -- Summit Biolabs, an early-stage molecular diagnostics company specializing in saliva liquid-biopsy tests for COVID-19 and head and neck cancer, announced it received funding from... Read More

Thursday November 19, 2020 0 comments Tags: Aurora, Summit Biolabs, Don Elliman, Bob Blomquist

Summit Biolabs, Center for Personalized Medicine to develop saliva tests for COVID, head & neck cancer

Summit Biolabs, Center for Personalized Medicine to develop saliva tests for COVID, head & neck cancer

AURORA -- Summit Biolabs, Inc. , an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head neck cancer, and the Colorado Center for Personalized... Read More

Thursday October 15, 2020 0 comments Tags: Aurora, Summit Biolabs, COVID-19, Colorado Center for Personalized Medicine, Kathleen Barnes, Bob Blomquist

Impressio and MedShape awarded grant from National Science Foundation to develop joint replacement device

Impressio and MedShape awarded grant from National Science Foundation to develop joint replacement device

AURORA -- Impressio Inc. and Atlanta-based MedShape Inc. have been awardeda National Science Foundation (NSF) Small Business Innovation Research (SBIR)grantfor $250,000to conduct research and... Read More

Wednesday July 29, 2020 0 comments Tags: Aurora, Impressio, MedShape, Amir Torbati, Christopher Yakacki

Neurexis Therapeutics awarded $250K Colorado Advanced Industries Accelerator Grant

Neurexis Therapeutics awarded $250K Colorado Advanced Industries Accelerator Grant

AURORA -- Neurexis Therapeutics, Inc. announced it has been approved for funding as part of the Colorado Office of Economic Development and International Trade’s (OEDIT) Advanced Industries... Read More

Wednesday June 3, 2020 0 comments Tags: Aurora, Neurexis Therapeutics, Ulli Bayer, Advanced Industries Accelerator Grants, Michael Artinger, Katie Woslager

Regeneron and Colorado Center for Personalized Medicine announce major new human genetics research collaboration

Regeneron and Colorado Center for Personalized Medicine announce major new human genetics research collaboration

AURORA -- New York-based Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and the Colorado Center for Personalized Medicine ( CCPM) at the University of Colorado Anschutz Medical Campus today... Read More

Tuesday May 12, 2020 0 comments Tags: Aurora, CCPM, Colorado Center for Personalized Medicine, Regeneron, Kathleen Barnes

Neurexis Therapeutics created to develop drug to tackle cerebral ischemia

Neurexis Therapeutics created to develop drug to tackle cerebral ischemia

AURORA -- VIC Technology Venture Development, LLC (VIC) announced the formation of Neurexis Therapeutics, Inc. to develop a new medication for the prevention of brain damage following ischemic... Read More

Monday April 27, 2020 0 comments Tags: Aurora, Neurexis Therapeutics, Ulli Bayer, Michael Artinger, Kimberly Muller

Greffex completes COVID-19 vaccine, prepares for FDA animal testing

Greffex completes COVID-19 vaccine, prepares for FDA animal testing

HOUSTON/AURORA -- Texas-based genetic engineering company Greffex, Inc. announced it has completed development of a Covid-19 vaccine and is ready to move on to animal testing as required by the U.S.... Read More

Thursday March 12, 2020 0 comments Tags: Aurora, Greffex, John Price, COVID-19, coronavirus

Women in CyberSecurity 2020 conference set for March 13-14 in Aurora

Women in CyberSecurity 2020 conference set for March 13-14 in Aurora

AURORA -- Women in CyberSecurity (WiCyS) is hosting its seventh annual conference, March 13-14, at the Gaylord Rockies Resort and Convention Center in Aurora. The event supports its mission to... Read More

Thursday February 20, 2020 0 comments Tags: Aurora, Women in CyberSecurity